Michael Beard

Research Interests

Innate Immunity Medical Virology

Prof Michael Beard

Professor

School of Biological Sciences

College of Sciences

Eligible to supervise Masters and PhD - email supervisor to discuss availability.

Associate Professor Michael Beard is head of the Viral Pathogenesis Research Laboratory (VPRL) at The University of Adelaide. He completed his PhD in molecular virology from the University of Queensland and after working in the USA with Stanley Lemon at UNC Chapel Hill he returned to Adelaide in 2002 and established the VPRL that focuses on the development of model systems to study complex cellular virus interactions with the ultimate aim to develop novel therapeutic strategies and understand how viruses cause disease. He has been continually funded by the NHMRC for 18 years. A main focus of his laboratory is the study of positive strand RNA viruses of the Flaviviridae family such as hepatitis C virus and other closely related viruses such as Dengue, West Nile Virus and more recently Zika virus. In particular his laboratory is interested in the innate immune response to viral infection and the host antiviral response through the expression of interferon stimulated genes (ISGs). Current projects use cutting edge molecular techniques such as, (i) CRISPR-related genome wide screens to identify novel host factors involved in viral life-cycles, (ii) development of human liver organoid cultures as a model of HBV infection and (iii) characterisation of the novel female hormonally regulated, interferon-epsilon in control of sexual transmission of ZIKV infection of the FRT and the development of novel therapeutics to modulate the innate immune environment of the FRT to limit sexually transmitted infections.

Date Position Institution name
2020 - ongoing Head of Department, Molecular and Biomedical Science The University of Adelaide
2016 - ongoing Faculty Member SAHMRI
2012 - ongoing Associate Professor The University of Adelaide
2010 - 2015 NHMRC Senior Reearch Fellow The University of Adelaide
2005 - 2009 NHMRC RD Wright Research Fellow SA Pathology
2002 - 2004 Royal Adelaide Hospital Florey Fellow Institute of Medical and Veterinary Science
2000 - 2002 Assistant Professor (Research) The University of Texas Medical Branch, Galveston
1997 - 1999 Postdoctoral Scientist University of Texas Medical Branch, Galveston
1996 - 1997 Postdoctoral Scientist University of North Carolina, Chapel Hill

Date Institution name Country Title
1996 The University of Queensland Australia PhD
1992 The University of Adelaide Australia BSc (Hons)
1983 - 1986 University of South Australia Australia Associate Diploma in Medical laboratory Science

Year Citation
2025 Van Der Hoek, K. H., Jankovic-Karasoulos, T., McCullough, D., Coldbeck-Shackley, R. C., Eyre, N. S., Roberts, C. T., & Beard, M. R. (2025). The first trimester human placenta responds to Zika virus infection inducing an interferon (IFN) and antiviral interferon stimulated gene (ISG) response. Virology Journal, 22(1), 108-1-108-15.
DOI WoS1
2025 Johnson, S. M., Centofanti, S. M., Bracho, G., Beard, M. R., Carr, J. M., & Eyre, N. S. (2025). Coatomer protein complex I is required for efficient secretion of dengue virus non-structural protein 1. Journal of Virology, 99(9), e0096225-1-e0096225-27.
DOI
2024 Kirby, E. N., Montin, X. B., Allen, T. P., Densumite, J., Trowbridge, B. N., & Beard, M. R. (2024). CRISPR activation as a platform to identify interferon stimulated genes with anti-viral function. Innate Immunity, 30(2-4), 40-54.
DOI Scopus1 WoS1 Europe PMC1
2023 Roennfeldt, A. E., Allen, T. P., Trowbridge, B. N., Beard, M. R., Whitelaw, M. L., Russell, D. L., . . . Peet, D. J. (2023). NanoFIRE: A NanoLuciferase and Fluorescent Integrated Reporter Element for Robust and Sensitive Investigation of HIF and Other Signalling Pathways. Biomolecules, 13(10), 1545-1-1545-16.
DOI
2023 Lim, C. K., Romeo, O., Tran, B. M., Flanagan, D. J., Kirby, E. N., McCartney, E. M., . . . Beard, M. R. (2023). Assessment of hepatitis B virus infection and interhost cellular responses using intrahepatic cholangiocyte organoids.. J Med Virol, 95(11), e29232.
DOI Scopus1 WoS1
2023 Coldbeck-Shackley, R. C., Romeo, O., Rosli, S., Gearing, L. J., Gould, J. A., Lim, S. S., . . . Beard, M. R. (2023). Constitutive expression and distinct properties of IFN-epsilon protect the female reproductive tract from Zika virus infection. PLoS Pathogens, 19(3), 1-26.
DOI Scopus15 WoS15 Europe PMC21
2023 Speck, P., Mackenzie, J., Bull, R. A., Slobedman, B., Drummer, H., Fraser, J., . . . Young, P. (2023). Statement in Support of: "Virology under the Microscope-a Call for Rational Discourse".. mSphere, 8(3), e0016523.
DOI
2023 Speck, P., Mackenzie, J., Bull, R. A., Slobedman, B., Drummer, H., Fraser, J., . . . Young, P. (2023). Statement in Support of: "Virology under the Microscope-a Call for Rational Discourse". mBio, 14(3), e0081523-1-e0081523-3.
DOI
2023 Speck, P., Mackenzie, J., Bull, R. A., Slobedman, B., Drummer, H., Fraser, J., . . . Young, P. (2023). Statement in Support of: "Virology under the Microscope-a Call for Rational Discourse". Journal of Virology, 97(5), 1-3.
DOI
2023 Tan, B. E. K., Beard, M. R., & Eyre, N. S. (2023). Identification of Key Residues in Dengue Virus NS1 Protein That Are Essential for Its Secretion. Viruses, 15(5), 1-21.
DOI Scopus14 WoS14 Europe PMC10
2022 Ryan, F. J., Hope, C. M., Masavuli, M. G., Lynn, M. A., Mekonnen, Z. A., Yeow, A. E. L., . . . Lynn, D. J. (2022). Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection. BMC Medicine, 20(1), 26-1-26-23.
DOI Scopus206 WoS204 Europe PMC202
2022 Garcia-Valtanen, P., Hope, C. M., Masavuli, M. G., Yeow, A. E. L., Balachandran, H., Mekonnen, Z. A., . . . Grubor-Bauk., B. (2022). SARS-CoV-2 Omicron variant escapes neutralising antibodies and T cell responses more efficiently than other variants in mild COVID-19 convalescents.. Cell Reports Medicine, 3(6), 100651-1-100651-17.
DOI Scopus34 WoS33 Europe PMC32
2022 Lim, C. K., Romeo, O., Chilver, A., Tran, B. M., Flanagan, D., Kirby, E., . . . Beard, M. (2022). Human Liver Organoids as a Patient-derived Model for HBV Infection and Cellular Response.
DOI
2021 Crosse, K. M., Monson, E. A., Dumbrepatil, A. B., Smith, M., Tseng, Y. -Y., Van Der Hoek, K. H., . . . Helbig, K. J. (2021). Viperin binds STING and enhances the type-I interferon response following dsDNA detection. Immunology and Cell Biology, 99(4), 373-391.
DOI Scopus31 WoS28 Europe PMC33
2021 Khantisitthiporn, O., Shue, B., Eyre, N. S., Nash, C. W., Turnbull, L., Whitchurch, C. B., . . . Beard, M. R. (2021). Viperin interacts with PEX19 to mediate peroxisomal augmentation of the innate antiviral response. Life Science Alliance, 4(7), e202000915-1-e202000915-14.
DOI Scopus7 WoS7 Europe PMC7
2021 Shue, B., Chiramel, A. I., Cerikan, B., To, T. -H., Frolich, S., Pederson, S. M., . . . Beard, M. R. (2021). Genome-wide CRISPR screen identifies RACK1 as a critical host factor for flavivirus replication. Journal of Virology, 95(24), e00596-21-1-e00596-21-18.
DOI Scopus40 WoS44 Europe PMC44
2021 Al Shujairi, W. -H., Kris, L. P., Van Der Hoek, K., Cowell, E., Bracho-Granado, G., Woodgate, T., . . . Carr, J. M. (2021). Viperin is anti-viral in vitro but is dispensable for restricting dengue virus replication or induction of innate and inflammatory responses in vivo. Journal of General Virology, 102(10), 001669-1-001669-14.
DOI Scopus6 WoS6 Europe PMC7
2021 Kirby, E. N., Shue, B., Thomas, P. Q., & Beard, M. R. (2021). CRISPR Tackles Emerging Viral Pathogens. Viruses, 13(11), 2157-1-2157-23.
DOI Scopus9 WoS8 Europe PMC11
2021 Garcia-Valtanen, P., Hope, C. M., Masavuli, M. G., Yeow, A. E. L., Balachandran, H., Mekonnen, Z. A., . . . Grubor-Bauk, B. (2021). COVID-19 convalescents exhibit deficient humoral and T cell responses to variant of concern Spike antigens at 12 month post-infection.
DOI
2020 Eyre, N. S., Kirby, E. N., Anfiteatro, D. R., Bracho, G., Russo, A. G., White, P. A., . . . Beard, M. R. (2020). Identification of estrogen receptor modulators as inhibitors of flavivirus infection. Antimicrob Agents Chemother, 8(64), 1-20.
DOI Scopus14 WoS25 Europe PMC26
2020 Helbig, K. J., Bull, R. A., Ambrose, R., Beard, M. R., Blanchard, H., Böcking, T., . . . Tachedjian, G. (2020). Tenth Scientific Biennial Meeting of the Australasian Virology Society-AVS10 2019. Viruses, 12(6), 621-1-621-23.
DOI Scopus1 WoS1 Europe PMC1
2020 Singleton, E. V., David, S. C., Davies, J. B., Hirst, T. R., Paton, J. C., Beard, M. R., . . . Alsharifi, M. (2020). Sterility of gamma-irradiated pathogens: a new mathematical formula to calculate sterilizing doses. Journal of Radiation Research, 61(6), 886-894.
DOI Scopus17 WoS16 Europe PMC12
2020 Coldbeck-Shackley, R. C., Eyre, N. S., & Beard, M. R. (2020). The molecular interactions of ZIKV and DENV with the type-i IFN response. Vaccines, 8(3), 530-1-530-21.
DOI Scopus32 WoS31 Europe PMC27
2019 Johnson, J., Freedman, H., Logan, M., Wong, J. A. J. -X., Hockman, D., Chen, C., . . . Houghton, M. (2019). A recombinant HCV genotype 1a E1/E2 envelope glycoprotein vaccine elicits antibodies that differentially neutralize closely related 2a strains through interactions of the N-terminal hypervariable region 1 of E2 with scavenger receptor B1. Journal of Virology, 93(22), e00810-19-1-e00810-19-15.
DOI Scopus18 WoS15 Europe PMC15
2019 Helbig, K. J., Teh, M. Y., Crosse, K. M., Monson, E. A., Smith, M., Tran, E. N., . . . Beard, M. R. (2019). The interferon stimulated gene viperin, restricts Shigella. flexneri in vitro.. Sci Rep, 9(1), 15598.
DOI Scopus20 WoS20 Europe PMC18
2019 Grubor-Bauk, B., Wijesundara, D. K., Masavuli, M., Abbink, P., Peterson, R. L., Prow, N. A., . . . Gowans, E. J. (2019). NS1 DNA vaccination protects against Zika infection through T cell-mediated immunity in immunocompetent mice.. Sci Adv, 5(12), eaax2388.
DOI Scopus65 WoS57 Europe PMC56
2018 Shahrudin, S., Chen, C., David, S., Singleton, E., Davies, J., Kirkwood, C., . . . Alsharifi, M. (2018). Gamma-irradiated rotavirus: a possible whole virus inactivated vaccine. PLoS ONE, 13(6), e0198182-1-e0198182-15.
DOI Scopus17 WoS15 Europe PMC14
2018 Adikusuma, F., Piltz, S., Corbett, M. A., Turvey, M., McColl, S. R., Helbig, K. J., . . . Thomas, P. Q. (2018). Large deletions induced by Cas9 cleavage. Nature, 560(7717), E8-E9.
DOI Scopus281 WoS275 Europe PMC290
2017 Eyre, N., Aloia, A., Joyce, M., Chulanetra, M., Tyrrell, L., & Beard, M. (2017). Sensitive luminescent reporter viruses reveal appreciable release of hepatitis C virus NS5A protein into the extracellular environment. Virology, 507, 20-31.
DOI Scopus21 WoS21 Europe PMC20
2017 Van Der Hoek, K., Eyre, N., Shue, B., Khantisitthiporn, O., Glab-Ampi, K., Carr, J., . . . Beard, M. (2017). Viperin is an important host restriction factor in control of Zika virus infection. Scientific Reports, 7(1), 4475 -1-4475-14.
DOI Scopus97 WoS95 Europe PMC84
2017 Nasr, N., Alshehri, A. A., Wright, T. K., Shahid, M., Heiner, B. M., Harman, A. N., . . . Cunningham, A. L. (2017). Mechanism of interferon stimulated gene induction in HIV-1 infected macrophages. Journal of Virology, 91(20), e00744-17-1-e00744-17-47.
DOI Scopus47 WoS48 Europe PMC48
2017 Eyre, N., Johnson, S., Eltahla, A., Aloi, M., Aloia, A., McDevitt, C., . . . Beard, M. (2017). Genome-wide mutagenesis of dengue virus reveals plasticity of the NS1 protein and enables generation of infectious tagged reporter viruses. Journal of Virology, 91(23), e01455-17-1-e01455-17-25.
DOI Scopus31 WoS31 Europe PMC28
2017 Crosse, K., Monson, E., Beard, M., & Helbig, K. (2017). Interferon-stimulated genes as enhancers of antiviral innate immune signaling. Journal of Innate Immunity, 10(2), 85-93.
DOI Scopus142 WoS135 Europe PMC129
2016 Clarke, J., Davies, L., Calvert, J., Gliddon, B., Al Shujari, W., Aloia, A., . . . Carr, J. (2016). Reduction in sphingosine kinase 1 influences the susceptibility to dengue virus infection by altering antiviral responses. Journal of General Virology, 97(1), 95-109.
DOI Scopus20 WoS17 Europe PMC17
2016 Eyre, N., Hampton-Smith, R., Aloia, A., Eddes, J., Simpson, K., Hoffmann, P., & Beard, M. (2016). Phosphorylation of NS5A Serine-235 is essential to hepatitis C virus RNA replication and normal replication compartment formation. Virology, 491, 27-44.
DOI Scopus30 WoS30 Europe PMC30
2016 Fiches, G., Eyre, N., Aloia, A., Van Der Hoek, K., Betz-Stablein, B., Luciani, F., . . . Beard, M. (2016). HCV RNA traffic and association with NS5A in living cells. Virology, 493, 60-74.
DOI Scopus9 WoS10 Europe PMC9
2016 Awan, Z., Tay, E., Eyre, N., Wu, L., Beard, M., Boo, I., . . . Douglas, M. (2016). Calsyntenin-1 mediates hepatitis C virus replication. Journal of General Virology, 97(8), 1877-1887.
DOI Scopus4 WoS4 Europe PMC6
2015 Aloia, A., Eyre, N., Black, S., Bent, S., Gaeguta, A., Guo, Z., . . . Beard, M. (2015). Generation of a chimeric hepatitis C replicon encoding a genotype-6a NS3 protease and assessment of boceprevir (SCH503034) sensitivity and drug-associated mutations.. Antiviral therapy, 20(3), 271-280.
DOI Scopus3 WoS2 Europe PMC4
2015 Tse, E., Helbig, K., Van der Hoek, K., McCartney, E., Van der Hoek, M., George, J., & Beard, M. (2015). Fatty acids induce a pro-inflammatory gene expression profile in Huh-7 cells that attenuates the anti-HCV action of interferon. Journal of Interferon and Cytokine Research, 35(5), 392-400.
DOI Scopus16 WoS16 Europe PMC12
2015 Mina, M., Luciani, F., Cameron, B., Bull, R., Beard, M., Booth, D., & Lloyd, A. (2015). Resistance to hepatitis C virus: potential genetic and immunological determinants. The Lancet Infectious Diseases, 15(4), 451-460.
DOI Scopus20 WoS20 Europe PMC16
2015 Milic, N., Davis, S., Carr, J., Isberg, S., Beard, M., & Helbig, K. (2015). Sequence analysis and characterisation of virally induced viperin in the saltwater crocodile (Crocodylus porosus). Developmental and Comparative Immunology, 51(1), 108-115.
DOI Scopus10 WoS10 Europe PMC7
2015 Calvert, J., Helbig, K., Dimasi, D., Cockshell, M., Beard, M., Pitson, S., . . . Carr, J. (2015). Dengue virus infection of primary endothelial cells induces innate immune responses, changes in endothelial cells function and is restricted by interferon-stimulated responses. Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, 35(8), 654-665.
DOI Scopus32 WoS29 Europe PMC26
2015 Narayana, S., Helbig, K., McCartney, E., Eyre, N., Bull, R., Eltahla, A., . . . Beard, M. (2015). The interferon-induced transmembrane proteins, IFITM1, IFITM2 and IFITM3 inhibit hepatitis C virus entry. Journal of Biological Chemistry, 290(43), 25946-25959.
DOI Scopus147 WoS144 Europe PMC143
2015 Green, T., Speck, P., Geng, L., Raftos, D., Beard, M., & Helbig, K. (2015). Oyster viperin retains direct antiviral activity and its transcription occurs via a signalling pathway involving a heat-stable haemolymph protein. Journal of General Virology, 96(12), 3587-3597.
DOI Scopus30 WoS26 Europe PMC20
2014 Eyre, N. S., & Beard, M. R. (2014). HCV NS5A inhibitors disrupt replication factory formation: a novel mechanism of antiviral action. Gastroenterology, 147(5), 959-962.
DOI Scopus11 Europe PMC8
2014 Eyre, N. S., & Beard, M. R. (2014). A mechanism for HCV NS5A-directed antiviral therapy. Gastroenterology, 147(5), 946-947.
DOI WoS2
2014 Eyre, N., Helbig, K., & Beard, M. (2014). Current and future targets of antiviral therapy in the hepatitis C virus life cycle. Future Virology, 9(11), 947-965.
DOI Scopus3 WoS3
2014 Beard, M. R., Ffrench, R., Gowans, E. J., Helbig, K. J., Eyre, N. M., Douglas, M. M. W., . . . Drummer, H. E. (2014). A summary of the 20th International Symposium on Hepatitis C Virus and Related Viruses. Gastroenterology, 147(1), e1-e4.
DOI Scopus1 WoS1
2014 Helbig, K., & Beard, M. (2014). The role of viperin in the innate antiviral response. Journal of Molecular Biology, 426(6), 1210-1219.
DOI Scopus175 WoS173 Europe PMC155
2014 Eyre, N., Fiches, G., Aloia, A., Helbig, K., McCartney, E., McErlean, C., . . . Beard, M. (2014). Dynamic imaging of the hepatitis C virus NS5A protein during a productive infection. Journal of Virology, 88(7), 3636-3652.
DOI Scopus50 WoS47 Europe PMC50
2013 McCartney, E., Helbig, K., Narayana, S., Eyre, N., Aloia, A., & Beard, M. (2013). Signal transducer and activator of transcription 3 is a proviral host factor for hepatitis C virus. Hepatology, 58(5), 1558-1568.
DOI Scopus53 WoS51 Europe PMC50
2013 Carr, J., Kua, T., Clarke, J., Calvert, J., Zebol, J., Beard, M., & Pitson, S. (2013). Reduced sphingosine kinase 1 activity in dengue virus type-2 infected cells can be mediated by the 3' untranslated region of dengue virus type-2 RNA. Journal of General Virology, 94(11), 2437-2448.
DOI Scopus30 WoS30 Europe PMC29
2013 Moriconi, F., Beard, M., & Yuen, L. (2013). Bioinformatics methods for the analysis of hepatitis viruses. Antiviral Therapy, 18(3 PARTB), 531-539.
DOI Scopus3 WoS3 Europe PMC1
2013 Helbig, K., Carr, J., Calvert, J., Wati, S., Clarke, J., Eyre, N., . . . Beard, M. (2013). Viperin is induced following dengue virus type-2 (DENV-2) infection and has anti-viral actions requiring the C-terminal end of viperin. PLoS Neglected Tropical Diseases, 7(4), 1-14.
DOI Scopus141 WoS140 Europe PMC128
2012 Aloia, A., Locarnini, S., & Beard, M. (2012). Antiviral resistance and direct-acting antiviral agents for HCV. Antiviral Therapy, 17(6 PART B), 1147-1162.
DOI Scopus25 WoS23 Europe PMC22
2012 Nasr, N., Maddocks, S., Turville, S., Harman, A., Woolger, N., Helbig, K., . . . Cunningham, A. (2012). HIV-1 infection of human macrophages directly induces viperin which inhibits viral production. Blood, 120(4), 778-788.
DOI Scopus194 WoS199 Europe PMC184
2012 Phillips, R., Helbig, K., Van Der Hoek, K., Seth, D., & Beard, M. (2012). Osteopontin increases hepatocellular carcinoma cell growth in a CD44 dependant manner. World Journal of Gastroenterology, 18(26), 3389-3399.
DOI Scopus35 WoS30 Europe PMC27
2012 Helbig, K., & Beard, M. (2012). The interferon signaling pathway genes as biomarkers of hepatitis C virus disease progression and response to treatment. Biomarkers in Medicine, 6(2), 141-150.
DOI Scopus4 WoS5 Europe PMC4
2012 Keoshkerian, E., Helbig, K., Beard, M., Zaunders, J., Seddiki, N., Kelleher, A., . . . Lloyd, A. (2012). A novel assay for detection of hepatitis C virus-specific effector CD4⁺ T cells via co-expression of CD25 and CD134. Journal of Immunological Methods, 375(1-2), 148-158.
DOI Scopus28 WoS28 Europe PMC23
2011 Suzuki, T., Ishida, T., Yamagishi, M., Ahlenstiel, C., Swaminathan, S., Marks, K., . . . Kelleher, A. (2011). Transcriptional gene silencing of HIV-1 through promoter targeted RNA is highly specific. RNA Biology, 8(6), 1035-1046.
DOI Scopus41 WoS40 Europe PMC38
2011 Helbig, K., Eyre, N., Yip, L., Narayana, S., Li, K., Fiches, G., . . . Beard, M. (2011). The antiviral protein viperin inhibits hepatitis C virus replication via interaction with nonstructural protein 5A. Hepatology, 54(5), 1506-1517.
DOI Scopus178 WoS174 Europe PMC165
2011 Fernandez, S., Tanaskovic, S., Helbig, K., Rajasuriar, R., Kramski, M., Murray, J., . . . French, M. (2011). CD4⁺ T-cell deficiency in HIV patients responding to antiretroviral therapy is associated with increased expression of interferon-stimulated genes in CD4⁺ T cells. Journal of Infectious Diseases, 204(12), 1927-1935.
DOI Scopus105 WoS102 Europe PMC95
2011 Berzsenyi, M., Woollard, D., McLean, C., Preiss, S., Perreau, V., Beard, M., . . . Roberts, S. (2011). Down-regulation of intra-hepatic T-cell signaling associated with GB virus C in a HCV/HIV co-infected group with reduced liver disease. Journal of Hepatology, 55(3), 536-544.
DOI Scopus21 WoS15 Europe PMC16
2011 McCartney, E., Eyre, N., & Beard, M. (2011). Border patrol intensifies for hepatitis C virus entry. Hepatology, 54(4), 1472-1475.
DOI Scopus2 Europe PMC1
2011 Wati, S., Rawlinson, S., Ivanov, R., Dorstyn, L., Beard, M., Jans, D., . . . Carr, J. (2011). Tumour necrosis factor alpha (TNF-α) stimulation of cells with established dengue virus type 2 infection induces cell death that is accompanied by a reduced ability of TNF-α to activate nuclear factor κB and reduced sphingosine kinase-1 activity. Journal of General Virology, 92(4), 807-818.
DOI Scopus46 WoS46 Europe PMC44
2011 Berzsenyi, M., Roberts, S., Preiss, S., Woollard, D., Beard, M., Skinner, N., . . . Visvanathan, K. (2011). Hepatic TLR2 & TLR4 expression correlates with hepatic inflammation and TNF-α in HCV & HCV/HIV infection. Journal of Viral Hepatitis, 18(12), 852-860.
DOI Scopus48 WoS47 Europe PMC40
2011 Thompson, A. J., Locarnini, S. A., & Beard, M. R. (2011). Resistance to anti-HCV protease inhibitors. Current Opinion in Virology, 1(6), 599-606.
DOI Scopus36 WoS36 Europe PMC30
2010 Eyre, N., Drummer, H., & Beard, M. (2010). The SR-BI partner PDZK1 facilitates Hepatitis C virus entry. PLoS Pathogens, 6(10), 1-14.
DOI Scopus54 WoS46 Europe PMC41
2010 Osna, N., White, R., Donohue, T., Beard, M., Tuma, D., & Kharbanda, K. (2010). Impaired methylation as a novel mechanism for proteasome suppression in liver cells. Biochemical and Biophysical Research Communications, 391(2), 1291-1296.
DOI Scopus31 WoS28 Europe PMC27
2010 Eyre, N., & Beard, M. (2010). Hepatitis C virus infection in living color. Hepatology, 51(5), 1852-1855.
DOI Scopus1 Europe PMC1
2010 McCartney, E., & Beard, M. (2010). Impact of alcohol on hepatitis C virus replication and interferon signaling. World Journal of Gastroenterology, 16(11), 1337-1343.
DOI Scopus38 WoS35 Europe PMC30
2009 Wati, S., Soo, M., Zilm, P., Li, P., Paton, A., Burrell, C., . . . Carr, J. (2009). Dengue Virus infection induces upregulation of GRP78, which acts to chaperone viral antigen production. Journal of Virology, 83(24), 12871-12880.
DOI Scopus96 WoS93 Europe PMC83
2009 Eyre, N., Baumert, T., & Beard, M. (2009). Closing the gap: The tight junction protein occludin and hepatitis C virus entry. Hepatology, 49(5), 1770-1772.
DOI Scopus1 Europe PMC1
2009 Eyre, N., Phillips, R., Bowden, S., Yip, L., Dewar, B., Locarnini, S., & Beard, M. (2009). Hepatitis B virus and hepatitis C virus interaction in Huh-7 cells. Journal of Hepatology, 51(3), 446-457.
DOI Scopus74 WoS62 Europe PMC57
2009 Helbig, K., Ruszkiewicz, A., Lanford, R., Berzsenyi, M., Harley, H., McColl, S., & Beard, M. (2009). Differential Expression of the CXCR3 Ligands in Chronic Hepatitis C Virus (HCV) Infection and Their Modulation by HCV In Vitro. Journal of Virology, 83(2), 836-846.
DOI Scopus66 WoS62 Europe PMC48
2008 Beard, M., & Helbig, K. (2008). Control of HCV replication: When size does not matter. Hepatology, 47(3), 1092-1094.
DOI Scopus1 Europe PMC1
2008 McCartney, E., Semendric, L., Helbig, K., Hinze, S., Jones, B., Weinman, S., & Beard, M. (2008). Alcohol metabolism increases the replication of hepatitis C virus and attenuates the antiviral action of interferon. Journal of Infectious Diseases, 198(12), 1766-1775.
DOI Scopus52 WoS47 Europe PMC42
2008 Helbig, K., Yip, L., McCartney, E., Eyre, N., & Beard, M. (2008). A screening method for identifying disruptions in interferon signaling reveals HCVNS3/4a disrupts Stat-1 phosphorylation. Antiviral Research, 77(3), 169-176.
DOI Scopus13 WoS12 Europe PMC11
2007 Phillips, R. J., Helbig, K. J., Ruszkiewicz, A. R., & Beard, M. R. (2007). Osteopontin is significantly expressed in advanced HCV-related liver disease and can accelerate huh-7 cell growth in vitro and in a nude mouse model. JOURNAL OF HEPATOLOGY, 46, S145.
DOI
2006 Beard, M., & Jones, B. (2006). Hepatitis C virus and oxidative stress: a dangerous liaison. Future Virology, 1(2), 223-232.
DOI WoS8
2006 Berzsenyi, M., Roberts, S., & Beard, M. (2006). Genomics of hepatitis B and C infections: diagnostic and therapeutic applications of microarray profiling. Antiviral Therapy, 11(5), 541-552.
DOI Scopus9 WoS6 Europe PMC5
2005 Helbig, K., Lau, D., Semendric, L., Harley, H., & Beard, M. (2005). Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effector. Hepatology, 42(3), 702-710.
DOI Scopus212 WoS211 Europe PMC185
2005 Lau, D., Luxon, B., Xiao, S., Beard, M., & Lemon, S. (2005). Intrahepatic gene expression profiles and alpha-smooth muscle actin patterns in hepatitis C virus induced fibrosis. Hepatology, 42(2), 273-281.
DOI Scopus62 WoS58 Europe PMC54
2005 Helbig, K., George, J., & Beard, M. (2005). A novel I-TAC promoter polymorphic variant is functional in the presence of replicating HCV in vitro. Journal of Clinical Virology, 32(2), 137-143.
DOI Scopus13 WoS14 Europe PMC13
2005 Locarnini, S., Shaw, T., Dean, J., Colledge, D., Thompson, A., Li, K., . . . Beard, M. (2005). Cellular response to conditional expression of the hepatitis B virus precore and core proteins in cultured hepatoma (Huh-7) cells. Journal of Clinical Virology, 32(2), 113-121.
DOI Scopus24 WoS19 Europe PMC16
2005 Otani, K., Korenaga, M., Beard, M., Li, K., Qian, T., Showalter, L., . . . Weinman, S. (2005). Hepatitis C virus core protein, cytochrome P450 2E1, and alcohol produce combined mitochondrial injury and cytotoxicity in hepatoma cells. Gastroenterology, 128(1), 96-107.
DOI Scopus127 WoS116 Europe PMC106
2004 Beard, M. (2004). Clinical outcome to interferon therapy in chronic hepatitis C: insights from mechanistic studies. Antiviral Therapy, 9(5), 637-639.
DOI
2004 Bigger, C., Guerra, B., Brasky, K., Hubbard, G., Beard, M., Luxon, B., . . . Lanford, R. (2004). Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees. Journal of Virology, 78(24), 13779-13792.
DOI Scopus243 WoS223 Europe PMC211
2004 Helbig, K., Ruszkiewicz, A., Semendric, L., Harley, H., McColl, S., & Beard, M. (2004). Expression of the CXCR3 ligand I-TAC by hepatocytes in chronic hepatitis C and its correlation with hepatic inflammation. Hepatology, 39(5), 1220-1229.
DOI Scopus108 WoS102 Europe PMC89
2004 Beard, M. R., & Locarnini, S. (2004). Monitoring gene expression using DNA microarrays during hepatitis B virus infection.. Methods in Molecular Medicine, 96, 55-64.
DOI
2002 Lerat, H., Honda, M., Beard, M. R., Loesch, K., Sun, J., Yang, Y., . . . Lemon, S. M. (2002). Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus. Gastroenterology, 122(2), 352-365.
DOI Scopus422 WoS380 Europe PMC334
2002 Okuda, M., Li, K., Beard, M. R., Showalter, L. A., Scholle, F., Lemon, S. M., & Weinman, S. A. (2002). Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology, 122(2), 366-375.
DOI Scopus855 WoS767 Europe PMC656
2002 Li, K., Prow, T., Lemon, S. M., & Beard, M. R. (2002). Cellular response to conditional expression of hepatitis C virus core protein in Huh7 cultured human hepatoma cells. Hepatology, 35(5), 1237-1246.
DOI Scopus91 WoS88 Europe PMC68
2001 Gale, M., & Beard, M. R. (2001). Molecular clones of hepatitis C virus: Applications to animal models. ILAR Journal, 42(2), 139-151.
DOI Scopus16 Europe PMC14
2001 Beard, M. R., Cohen, L., Lemon, S. M., & Martin, A. (2001). Characterization of recombinant hepatitis A virus genomes containing exogenous sequences at the 2A/2B junction. Journal of Virology, 75(3), 1414-1426.
DOI Scopus31 WoS25 Europe PMC21
2001 Xiao, S. Y., Wang, H. L., Hart, J., Fleming, D., & Beard, M. R. (2001). Cdna arrays and immunohistochemistry identification of cd10/calla expression in hepatocellular carcinoma. American Journal of Pathology, 159(4), 1415-1421.
DOI Scopus74 WoS71 Europe PMC56
2000 Lemon, S. M., Lerat, H., Honda, M., Loesch, K., West, B., Okuda, M., . . . Weinman, S. A. (2000). Hepatic Steatosis and Hepatocellular Carcinoma in Hepatitis C Transgenic Mice. Acta Hepatologica Japonica, 41(supl1), A27-A32.
DOI
2000 Blank, C. A., Anderson, D. A., Beard, M., & Lemon, S. M. (2000). Infection of polarized cultures of human intestinal epithelial cells with hepatitis A virus: Vectorial release of progeny virions through apical cellular membranes. Journal of Virology, 74(14), 6476-6484.
DOI Scopus66 WoS52 Europe PMC43
1999 Honda, M., Beard, M. R., Ping, L. H., & Lemon, S. M. (1999). A phylogenetically conserved stem-loop structure at the 5' border of the internal ribosome entry site of hepatitis C virus is required for cap- independent viral translation. Journal of Virology, 73(2), 1165-1174.
DOI Scopus247 WoS222 Europe PMC193
1999 Beard, M. R., Abell, G., Honda, M., Carroll, A., Gartland, M., Clarke, B., . . . Lemon, S. M. (1999). An infectious molecular clone of a Japanese genotype 1b hepatitis C virus. Hepatology, 30(1), 316-324.
DOI Scopus122 WoS111 Europe PMC108
1996 Beard, M. R., MacNaughton, T. B., & Gowans, E. J. (1996). Identification and characterization of a hepatitis delta virus RNA transcriptional promoter. Journal of Virology, 70(8), 4986-4995.
DOI Scopus66 WoS62 Europe PMC53
1993 Macnaughton, T. B., Beard, M. R., Chao, M., Gowans, E. J., & Lai, M. M. C. (1993). Endogenous Promoters Can Direct the Transcription of Hepatitis Delta Virus RNA from a Recircularized cDNA Template. Virology, 196(2), 629-636.
DOI Scopus37 WoS34 Europe PMC27

Year Citation
2018 Colledge, D., Jackson, K., Sozzi, V., Li, X., Beard, M. R., Eyre, N., . . . Locarnini, S. (2018). Inarigivir Is a Novel Selective Inhibitor of the HBV Replicase Complex in Vitro. In HEPATOLOGY Vol. 68 (pp. 229A). San Francisco, CA: WILEY.
WoS4
2011 McCartney, E. M., Helbig, K. J., & Beard, M. R. (2011). THE ROLE OF SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 3 (STAT3) IN THE HCV LIFE CYCLE. In JOURNAL OF HEPATOLOGY Vol. 54 (pp. S307). Berlin, GERMANY: ELSEVIER.
DOI
2010 Eyre, N. S., Turville, S., & Beard, M. (2010). LIVE CELL IMAGING OF HEPATITIS C VIRUS NS5A TRAFFIC DURING AN INFECTIOUS LIFE CYCLE. In HEPATOLOGY Vol. 52 (pp. 376A-377A). Boston, MA: WILEY-BLACKWELL.
2009 Berzsenyi, M. D., Woollard, D. J., McLean, C. A., Preiss, S., Perreau, V. M., Beard, M. R., . . . Roberts, S. K. (2009). DIFFERENTIAL INTRA-HEPATIC T-CELL SIGNALLING ASSOCIATED WITH GB VIRUS C IN HCV/HIV CO-INFECTION. In HEPATOLOGY Vol. 50 (pp. 949A). Boston, MA: JOHN WILEY & SONS INC.
2009 Austin, L., Kharbanda, K. K., Beard, M. R., & Osna, N. A. (2009). ETHANOL AFFECTS EXPRESSION OF RECEPTORS FOR HCV ENTRY IN LIVER CELLS. In HEPATOLOGY Vol. 50 (pp. 1155A-1156A). Boston, MA: JOHN WILEY & SONS INC.
WoS2
2008 Osna, N. A., Donohue, T. M., White, R. L., Beard, M. R., & Kharbanda, K. K. (2008). ETHANOL AND HEPATITIS C VIRAL (HCV) PROTEINS REGULATE INTERFERON (IFN) SIGNALING IN LIVER CELLS VIA IMPAIRED METHYLATION OF STAT1. In HEPATOLOGY Vol. 48 (pp. 327A-328A). San Francisco, CA: JOHN WILEY & SONS INC.
WoS5
2006 Seth, D., Beard, M. R., Gorrell, M. D., McCaughan, G. W., & Haber, P. S. (2006). Osteopontin: An early marker for alcoholic liver injury?. In ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH Vol. 30 (pp. 89A). Sydney, AUSTRALIA: BLACKWELL PUBLISHING.
WoS2
2004 Helbig, K. J., Semendric, L., & Beard, M. R. (2004). <i>In vitro</i> modulation of the CXCR3 chemokine I-TAC by HCV replication is influenced by a novel I-TAC promoter polymorphic variant.. In HEPATOLOGY Vol. 40 (pp. 438A). Boston, MA: JOHN WILEY & SONS INC.
2004 Beard, M. R., Semendric, L., Helbig, K. J., Otani, K., & Weinman, S. A. (2004). HCV replication is enhanced in the presence of CYP2E1 and alcohol. In HEPATOLOGY Vol. 40 (pp. 198A-199A). Boston, MA: JOHN WILEY & SONS INC.
2002 Shaw, T., Dean, J., Locarnini, S., & Beard, M. R. (2002). DNA microarray analyses show that lamivudine affects gene expression in HEPG2 cells: Implications for chemotherapy of chronic HBV infection. In HEPATOLOGY Vol. 36 (pp. 633A). BOSTON, MASSACHUSETTS: W B SAUNDERS CO.
2002 Otani, K., Beard, M. R., & Weinman, S. A. (2002). Cellular models for the study of alcohol-hepatitis C interactions.. In HEPATOLOGY Vol. 36 (pp. 398A). BOSTON, MASSACHUSETTS: W B SAUNDERS CO.
2002 Lau, D. T. Y., Ma, H. B., Abdo, B. O., Luxon, B. A., Sinha, M., & Beard, M. R. (2002). Differential hepatic gene expression profiles between steatosis and fibrosis in patients with non-alcoholic fatty liver disease (NAFLD). In GASTROENTEROLOGY Vol. 122 (pp. A672). W B SAUNDERS CO.

Year Citation
2019 Colledge, D., Jackson, K., Sozzi, V., Li, X., Beard, M., Eyre, N., . . . Locarnini, S. (2019). The novel antiviral agent inarigivir inhibits both nucleos (t)ide analogue and capsid assembly inhibitor resistant HBV in vitro. Poster session presented at the meeting of JOURNAL OF HEPATOLOGY. Vienna, AUSTRIA: ELSEVIER.
DOI
2019 Lim, C. K., Tran, B. M., Shue, B., Eyre, N., Flanagan, D., Vincan, E., . . . Beard, M. (2019). Human liver organoids culture as a novel in vitro model of HBV infection. Poster session presented at the meeting of JOURNAL OF HEPATOLOGY. Vienna, AUSTRIA: ELSEVIER.
2014 Tse, E. Y., Helbig, K. J., Van der Hoek, K., McCartney, E. M., George, J., & Beard, M. R. (2014). FATTY ACIDS INDUCE A PRO-INFLAMMATORY GENE EXPRESSION PROFILE IN HUH-7 CELLS AND ATTENUATE THE ANTI-HCV ACTION OF INTERFERON. Poster session presented at the meeting of JOURNAL OF HEPATOLOGY. London, ENGLAND: ELSEVIER SCIENCE BV.
DOI
2013 Muller, K. R., Eyre, N. S., Van der Hoek, K. H., Li, K., & Beard, M. R. (2013). The effect of hepatitis C virus-infected Huh-7 cells on 'bystander' cells. Poster session presented at the meeting of Journal of Gastroenterology and Hepatology. Melbourne, Vic.: Wiley.
DOI
2012 Aloia, A. L., Carr, J., Eyre, N. S., Locarnini, S., Lemon, S., & Beard, M. R. (2012). Development of a genotype 6a/1b chimeric replicon for testing of direct acting antivirals against the HCV protease. Poster session presented at the meeting of HEPATOLOGY. Boston, MA: WILEY-BLACKWELL.
2009 Berzsenyi, M. D., Woollard, D. J., McLean, C. A., Preiss, S., Perreau, V. M., Beard, M. R., . . . Roberts, S. K. (2009). Differential intra-hepatic T-cell signalling associated with GB virus C in HCV/HIV co-infection. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL PUBLISHING, INC.

Year Citation
- Roennfeldt, A., Allen, T., Trowbridge, B., Beard, M., Whitelaw, M., Russell, D., . . . Peet, D. (n.d.). Graph Pad prism files of all data published in Roennfeldt et al. (2023). Data points for each experiment represents the mean of an individual replicate (and thus each experiment was completed in triplicate with the mean +/- standard deviation graphed)..
DOI

Year Citation
2024 Johnson, S. M., Centofanti, S. M., Bracho, G., Beard, M. R., Carr, J. M., & Eyre, N. S. (2024). Coatomer protein complex I is required for efficient secretion of dengue virus non-structural protein 1.
DOI
2023 Kirby, E., Montin, X., Allen, T., Densumite, J., Trowbridge, B., & Beard, M. (2023). The utility of CRISPR activation as a platform to identify interferon stimulated genes with anti-viral function.
DOI
2021 Ryan, F., Hope, C., Masavuli, M., Lynn, M., Mekonnen, Z., Lip Yeow, A. E., . . . Lynn, D. (2021). Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection.
DOI Europe PMC1

 

2020.               Beard M; Lim C; Warner N.  Liver organoid culture as a platform for novel HBV antiviral testing. Australian Centre for HIV and Hepatitis Virology Research. $85,000.00

2020-2022       Doonan C; Sumby C; Bell S; Beard M; Falcaro P.  Advancing the Chemistry of Metal-organic Frameworks for Biotechnology. ARC DP200102411. $550,000.00

2018-2020.     Beard, Helbig, Lemon, Eyre. NHMRC Project Grant APP1145613.  The interplay between viperin, peroxisomes and the cellular innate antiviral response. $556,127

2014-2018       Lloyd, Dore, George, Beard.  NHMRC Program Grant APP1053206. Title: Hepatitis C infection: epidemiology pathogenesis    and treatment. $5,427,855.00

2015-2016       KJ Helbig, MR Beard, P Revill, P Thomas. Targeting HBV cccDNA using the CRISPR/Cas system. $169,000. Australian Centre for HIV and Hepatitis Virology Research

2010-2015       Beard M. NHMRC Senior Research Fellowship $560,000 total

2009-2013       Cooper, Beard, Dore, Emery, French, Kelleher, Kent, Purcell.  NHMRC Program Grant #510448. Title: HIV and HCV Vaccines and Immunopathogenesis.  $17,800,000 ($395,000/year/investigator)      

2012-2014       Michael Beard, Nicholas Eyre and Stuart Turville. (2012-2014) Imaging the hepatitis C virus life cycle in living cells.  NHMRC Project Grant  APP1027641  Total: $461,325.000

2012                Michael Beard, Jill Carr and Stephen Locarnini. Analysis of Boceprevir drug susceptibility and resistance in HCV genotype 6. Merck Investigator Studies Program $115,000

2011-2012       Beard M and Locarnini S. Phase II. Development of a laboratory based platform to manage patients who develop antiviral drug-resistance to the STAT-C compounds. ACH2 $113,000 tot

2010-2011       Beard M and Locarnini S. Development of a laboratory based platform to manage patients who develop antiviral drug-resistance to the STAT-C compounds. ACH2 $142,000 total

2010-2011       Beard M and Shackel N. Ultra-deep sequencing of hepatitis C and hepatocytes following interferon exposure Roche Pillar Award. $40,000 total

2008-2010       Beard M & Helbig K. NHMRC Project Grant # 508088  Identification of interferon stimulated genes that limit HCV replication and predict therapeutic outcome. $468,750 total

Date Role Research Topic Program Degree Type Student Load Student Name
2024 Co-Supervisor Harnessing the potential of mRNA vaccines against Hepatitis C Virus Doctor of Philosophy Doctorate Full Time Mr John Henrik Johansson
2024 Co-Supervisor Harnessing the potential of mRNA vaccines against Hepatitis C Virus Doctor of Philosophy Doctorate Full Time Mr John Henrik Johansson
2022 Principal Supervisor CRISPR Screening Systems to Identify Novel Virus-Host Interactions and Innate Immune Pathways Doctor of Philosophy Doctorate Full Time Mr Xavier Bernard Montin
2022 Principal Supervisor CRISPR Screening Systems to Identify Novel Virus-Host Interactions and Innate Immune Pathways Doctor of Philosophy Doctorate Full Time Mr Xavier Bernard Montin

Date Role Research Topic Program Degree Type Student Load Student Name
2021 - 2025 Principal Supervisor Understanding the impact of hypoxia and associated signalling pathways on ZIKV and DENV replication and innate antiviral responses Doctor of Philosophy Doctorate Full Time Miss Brooke Nyree Trowbridge
2020 - 2023 Principal Supervisor Identification of dengue virus (DENV) NS1 protein residues involved in its cellular secretion and host factors involved in NS1 protein N-glycosylation Doctor of Philosophy Doctorate Full Time Mr Eng Kuan Brandon Tan
2019 - 2023 Principal Supervisor CRISPR Activation as a Tool to Identify Anti-viral Host Factors Doctor of Philosophy Doctorate Full Time Miss Emily Nicole Kirby
2018 - 2021 Principal Supervisor Molecular Characterisation of Flavivirus Interactions with the Host Innate Immune Response Doctor of Philosophy Doctorate Full Time Ms Rosa Cedar Coldbeck-Shackley
2017 - 2020 Co-Supervisor Sterility and Immunogenicity of Gamma Irradiated Respiratory Viruses Doctor of Philosophy Doctorate Full Time Miss Eve Victoria Singleton
2017 - 2022 Principal Supervisor Human Liver Organoids Culture as a Personalised Approach in Assessing HBV Infection and Cellular Responses Doctor of Philosophy Doctorate Full Time Dr Chuan Kok Lim
2015 - 2021 Principal Supervisor Identification of Proviral and Host Restriction Factors that Impact the Flaviviridae Lifecycle Doctor of Philosophy Doctorate Full Time Mr Byron Shue
2013 - 2018 Principal Supervisor The Novel Interacting Partners of Viperin and their Role in Establishing a Host Antiviral State Doctor of Philosophy Doctorate Full Time Ms Onruedee Khantisitthiporn
2011 - 2015 Principal Supervisor Defining and Characterising the anti-HCV Actions of the Interferon-Induced Transmembrane Proteins Doctor of Philosophy Doctorate Full Time Miss Sumudu Kumari Narayana
2011 - 2015 Principal Supervisor Dynamic Imaging of Hepatitis C Virus RNA Localisation and Traffic During Viral Replication Doctor of Philosophy Doctorate Full Time Mr Guillaume Fiches
2010 - 2015 Principal Supervisor The Bystander Effect in Hepatitis C Virus Infection: Cellular Interactions Between Infected Cells and Uninfected Cells Doctor of Philosophy Doctorate Full Time Ms Kate Rebecca Muller
2009 - 2015 Principal Supervisor Improving treatment predictors of HCV therapy and the impact of steatosis on the hepatocyte transcriptome and anti-HCV action of interferon Doctor of Philosophy Doctorate Part Time Prof Edmund Yee-Lai Tse
2007 - 2012 Co-Supervisor Molecular Analysis of Acute and Chronic Duck Hepatitis B Virus (DHBV) Infections in Ducks Doctor of Philosophy Doctorate Full Time Miss Huey Low
2007 - 2014 Co-Supervisor DEVELOPMENT AND ASSESSMENT OF NOVEL VACCINATION STRATEGIES FOR HEPATITIS B VIRUS INFECTION Doctor of Philosophy Doctorate Full Time Mr Devin Teoh
2006 - 2011 Principal Supervisor Molecular Interactions Between Alcohol, Hepatitis C Virus and Interferon Doctor of Philosophy Doctorate Full Time Dr Erin McCartney
2005 - 2010 Co-Supervisor Development of Antiviral Therapies for Hepatitis B Virus Infection Doctor of Philosophy Doctorate Full Time Miss Faseeha Noordeen
2004 - 2008 Co-Supervisor Characterisation of the Events Involved in the Resolution of Acute Duck Hepatitis B Virus Infection Doctor of Philosophy Doctorate Full Time Dr Georget Reaiche
2004 - 2010 Principal Supervisor Expression and function of osteopontin variants in HCV-related liver disease and hepato-cellular carcinoma Doctor of Philosophy Doctorate Full Time Dr Renee Phillips

Date Role Committee Institution Country
2015 - ongoing Member Lorne Infection and Immunity Conference - -
2010 - ongoing Member Organising Committee International Symposium on HCV and Related Viruses - -

Date Role Editorial Board Name Institution Country
2017 - ongoing Associate Editor Virology Journal - -
2013 - ongoing Advisory Board Member Journal of Interferon and Cytokine Research - -

Connect With Me

External Profiles

Other Links